Lynnwood, WA, United States of America

Ekaterina G Makienko

This inventor holds 2 USPTO granted patents. Top assignee: Mdrna, Inc.. Active years: 2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ekaterina G Makienko. Retrieved from https://idiyas.com/inventor/ekaterina-g-makienko

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 4.0

ph-index = 2

Forward Citations = 29(Granted Patents)


Company Filing History:


Years Active: 2010

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Ekaterina G Makienko: Innovator in Biochemical Engineering

Introduction

Ekaterina G Makienko is a prominent inventor based in Lynnwood, WA (US). She has made significant contributions to the field of biochemical engineering, particularly in the development of novel polypeptides with unique binding properties. Her work has led to the filing of multiple patents, showcasing her innovative approach to scientific challenges.

Latest Patents

Ekaterina holds 2 patents that focus on phage displayed cell binding peptides. The first patent provides a detailed disclosure on the construction, expression, and selection of mutated genes that encode novel Trp cage polypeptides. These polypeptides exhibit desirable binding properties and can target a variety of biological and synthetic macromolecules. The invention emphasizes the genetic variants of Trp cage-encoding nucleic acids achieved through controlled random mutagenesis, resulting in a mixture of polypeptides capable of binding to various targets.

The second patent also relates to phage displayed cell binding peptides, detailing the construction and selection of genes that encode Trp cage polypeptides with specific cell and tissue binding properties. This innovation includes a polypeptide that may contain a specific amino acid sequence, enhancing its binding capabilities.

Career Highlights

Ekaterina is currently associated with Moderna, Inc., a leading biotechnology company known for its groundbreaking work in mRNA technology. Her role at Moderna allows her to apply her expertise in polypeptide engineering to develop innovative solutions in the field of medicine.

Collaborations

Throughout her career, Ekaterina has collaborated with notable professionals, including Richard E Herman and Douglas L Badders. These collaborations have further enriched her research and contributed to her success as an inventor.

Conclusion

Ekaterina G Makienko is a trailblazer in the field of biochemical engineering, with a focus on innovative polypeptides that have the potential to revolutionize various applications. Her contributions through patents and collaborations highlight her commitment to advancing scientific knowledge and technology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…